Your browser doesn't support javascript.
loading
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Fader, Amanda N; Roque, Dana M; Siegel, Eric; Buza, Natalia; Hui, Pei; Abdelghany, Osama; Chambers, Setsuko; Secord, Angeles Alvarez; Havrilesky, Laura; O'Malley, David M; Backes, Floor J; Nevadunsky, Nicole; Edraki, Babak; Pikaart, Dirk; Lowery, William; ElSahwi, Karim; Celano, Paul; Bellone, Stefania; Azodi, Masoud; Litkouhi, Babak; Ratner, Elena; Silasi, Dan-Arin; Schwartz, Peter E; Santin, Alessandro D.
Afiliação
  • Fader AN; John Hopkins School of Medicine, Baltimore, Maryland.
  • Roque DM; University of Maryland, Baltimore, Maryland.
  • Siegel E; University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Buza N; Yale University, New Haven, Connecticut.
  • Hui P; Yale University, New Haven, Connecticut.
  • Abdelghany O; Yale University, New Haven, Connecticut.
  • Chambers S; University of Arizona, Tucson, Arizona.
  • Secord AA; Duke University School of Medicine, Durham, North Caroline.
  • Havrilesky L; Duke University School of Medicine, Durham, North Caroline.
  • O'Malley DM; The Ohio State University School of Medicine, Columbus, Ohio.
  • Backes FJ; The Ohio State University School of Medicine, Columbus, Ohio.
  • Nevadunsky N; Albert Einstein College/Montefiore Medical Center, Bronx, New York.
  • Edraki B; John Muir Medical Center, Walnut Creek, California.
  • Pikaart D; Penrose Cancer Center-St. Francis, Colorado Springs, Colorado.
  • Lowery W; Walter Reed Medical Center, Bethesda, Maryland.
  • ElSahwi K; Hackensack Meridian Health, Neptune, New Jersey.
  • Celano P; Greater Baltimore Medical Center, Baltimore, Maryland.
  • Bellone S; Yale University, New Haven, Connecticut.
  • Azodi M; Yale University, New Haven, Connecticut.
  • Litkouhi B; Stanford Women's Cancer Center, Palo Alto, California.
  • Ratner E; Yale University, New Haven, Connecticut.
  • Silasi DA; Yale University, New Haven, Connecticut.
  • Schwartz PE; Yale University, New Haven, Connecticut.
  • Santin AD; Yale University, New Haven, Connecticut. alessandro.santin@yale.edu.
Clin Cancer Res ; 26(15): 3928-3935, 2020 08 01.
Article em En | MEDLINE | ID: mdl-32601075
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio / Cistadenocarcinoma Seroso / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio / Cistadenocarcinoma Seroso / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article